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ABSTRACT
While it is widely acknowledged that the ubiquitin–
proteasome system plays an important role in tran-
scription, little is known concerning the mechanistic
basis, in particular the spatial organization of
proteasome-dependent proteolysis at the transcrip-
tion site. Here, we show that proteasomal activity
and tetraubiquitinated proteins concentrate to
nucleoplasmic microenvironments in the euchroma-
tin. Such proteolytic domains are immobile and dis-
tinctly positioned in relation to transcriptional
processes. Analysis of gene arrays and early
genes in Caenorhabditis elegans embryos reveals
that proteasomes and proteasomal activity are dis-
tantly located relative to transcriptionally active
genes. In contrast, transcriptional inhibition
generally induces local overlap of proteolytic
microdomains with components of the transcription
machinery and degradation of RNA polymerase II.
The results establish that spatial organization of
proteasomal activity differs with respect to distinct
phases of the transcription cycle in at least some
genes, and thus might contribute to the plasticity
of gene expression in response to environmental
stimuli.
INTRODUCTION
The nucleus stores the genetic information for the integra-
tion of physiological signals that control proliferation and
phenotypic properties of cells. Gene expression pro-
grammes are launched in the nucleus that represent end
points of a great many signal transduction pathways, thus
enabling cellular responses to a plethora of environmental
stimuli. After the genomes of man and prevalent model
organisms have been decoded, it has become increasingly
clear that regulation of gene expression, e.g. the execution
of different genetic programmes, requires more than the
characterization of respective DNA sequences. Nuclear
processes as well as their regulatory machinery are
organized by a functional architecture that manifests
itself in focal nuclear domains or microenvironments con-
sisting of (ribo-) nucleic acids, proteins and dynamic
complexes thereof (1–4).
Transcription constitutes the ﬁrst step in gene expres-
sion. It is divided into a sequence of initiation, promoter
clearance, elongation and termination. Initiation of
mRNA synthesis in eukaryotes requires assembly of
 100 protein subunits that form a scaffold of speciﬁc or
general transcription factors, transcriptional co-activators,
co-repressors, chromatin remodelling complexes, the
mediator and the RNA polymerase II (RNAPII) holoen-
zyme (5–7). While the C-terminal domain (CTD) of the
largest RNAPII subunit is usually hypophosphorylated
during formation of the initiation complex, the transi-
tion into the elongation phase coincides with
hyperphosphorylation of the CTD by kinases including
subunit CDK7 (in metazoans) of general transcription
factor TFIIH (8). Thus, antibodies that speciﬁcally recog-
nize the phosphorylation state of RNAPII’s CTD are used
to detect respective steps of transcription, and localize ini-
tiation and elongation foci scattered throughout the nu-
cleoplasm (9). Visualization of newly synthesized mRNA
by incorporation and immediate detection of nucleotide
analogues corroborates that transcriptional elongation
occurs in hundreds of focal transcription factories per
nucleus (10). Both, transcriptional activation and
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somal targets results in gene arrays that facilitate obser-
vation of ‘enhanced’ transcription events at a single locus.
Such gene array-based techniques showed that (i) the
glucocorticoid receptor (GR) activates transcription of re-
sponsive genes by transient interaction at an MMTV
promoter with a residence half-time in the seconds range
(11), (ii) components of the RNAPI machinery assemble
on endogenous ribosomal DNA as distinct subunits and
scaffolding occurs via metastable intermediates (12),
(iii) assembly of the RNAPII machinery is inefﬁcient
since just 1% of polymerase-binding events result in
complete transcription of mRNA (13) and (iv) some tran-
scriptionally active chromatin is compacted more than the
30-nm chromatin ﬁbre, and might decondense only in
immediate proximity to the polymerase during transcrip-
tion (14).
While regulation of gene expression occurs at all steps
that lie between the synthesis of an RNA molecule and the
completion of the respective protein, assembly and kinetic
organisation of the transcription machinery both repre-
sent an early and major target of control. Besides integra-
tion of cell signalling pathways by co-activators,
management of chromatin accessibility through epigenetic
tagging, molecular switches and composition of the
mediator, the ubiquitin–proteasome system represents an
additional layer of transcriptional regulation in messenger
RNA synthesis (15–18). It has been suggested that com-
ponents of the 26S proteasome, which is made up of two
ﬂanking 19S regulatory caps and a 20S proteolytic
chamber, might clear the initiation complex by freeing
RNAPII, thus enabling progression into the elongation
phase. Consistently, inactivation of the 19S subunit
Sug1/Rpt6 results in defects of transcriptional elongation
in yeast (19). However, it was likewise shown that the 19S
regulatory caps of the proteasome can act independently
of the 20S proteolytic particle and are recruited to the
GAL1-10 promoter by the Gal4 transactivator upon in-
duction with galactose (20). In this context, the prote-
asome might not be executing its proteolytic function,
but, instead, the 19S regulator/y cap might use its
ATPase subunits as chaperones for non-proteolytic
remodelling of protein conformations and/or interactions.
In line with this, it was demonstrated that the ATPase
activity of the 19S regulator has an important function
in targeting the SAGA histone–acetylase complex to pro-
moters and stimulates its interaction with transcriptional
activators (21).
Besides the non-proteolytic and 20S proteasome-
independent involvement of the 19S regulator in transcrip-
tion processes, proteasomal protein degradation has been
implicated in turnover of transcriptional activators
(22–24) that might enable progression into the elongation
phase by resetting the promoter (25). Genomic localiza-
tion analysis and transcriptional proﬁling with three com-
ponents of the yeast proteasome that have either
regulatory or catalytic functions identiﬁed target genes
including highly transcribed genes, genes controlled by
mating type loci, genes involved in lipid metabolism and
ribosomal protein genes (26). In these studies, similar
genomic occupancies of proteasomal subunits and
transcriptional activators Spt23 and Mga2 suggest con-
certed regulatory activity of proteasomes and their tran-
scription factor substrates. It should be noted that
proteolytic activity at the promoters was not investigated.
In addition to their role at the promoter, proteasomes
have also been associated with clearance of stalled tran-
scription machineries and transcriptional termination,
since they physically associate with transcriptionally
active genes at sites of DNA damage and concentrate at
the 30 ends of these genes (27). Consistent with this idea,
inhibitors of proteasome-dependent protein degradation
impair the recognition of termination sites.
While participation of the ubiquitin–proteasome system
in transcription might be attributable to both proteolytic
and non-proteolytic functions, it is unclear whether local
association of proteasomal activity at a transcriptionally
active gene is needed for its expression. Here, we
investigated the spatial and temporal organization of
two nuclear processes: proteasomal proteolysis and tran-
scription. Using ectopic as well as endogenous gene
arrays, we show that local association of proteasomes
and proteasome-dependent proteolysis with the transcrip-
tion machinery is not required for transcriptional initi-
ation, elongation and protein synthesis of every gene.
Consistent with this, emerging transcriptional activity in
Caenorhabditis elegans embryos is characterized by local
segregation of proteasomes and sites of transcriptional
elongation. In contrast, under conditions of transcription-
al inhibition substrates such as RNAPII and components
of the RNA processing machinery concentrate in focal
microenvironments that contain proteolytic activity.
MATERIALS AND METHODS
Strain maintenance, cell culture, transfection and
treatments
Wild-type C. elegans N2 stocks were maintained at 20 C
using standard methods (28). HEp-2 cells (American
Tissue Culture Collection) were cultured in RPMI 1640
medium supplemented with 10% fetal bovine serum
(FBS), nonessential amino acids, L-glutamine and penicil-
lin and streptomycin (pen/strep). Murine embryonic ﬁbro-
blasts (kind gift from Peter Hemmerich) were cultured in
low-glucose Dulbecco’s modiﬁed eagle medium (DMEM)
supplemented with 10% FBS, nonessential amino acids,
L-glutamine and pen/strep. E3 cells (29) were cultured in
low-glucose DME containing 10% FBS. E3 cells were
transiently transfected with expression plasmids using
FuGene 6 (Roche) for 24–30h according to the manufac-
turer’s protocol. The following plasmids were used:
MS2-GFP. Transcription of the transgene was induced
using 6mg/ml doxycycline overnight. Transcriptional in-
hibition was induced by adding AMD (1mg/ml) or
HgCl2 (60mM) for 4h. For in situ localization of
proteasomal protein degradation under conditions of
RNA polymerase I inhibition, HgCl2 (50–70mM) and
DQ-Ova were comicroinjected into the nucleus and cells
were incubated between 60 and 90min before ﬁxation.
Where indicated, cells were coincubated with 1–5mM
MG132 for 16h to inhibit proteasomal activity.
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The following antibodies were used for indirect immuno-
ﬂuorescence (IF) or western blot (WB) where indicated:
human anti-K48 linked polyubiquitin (Apu2.07; 30) at
1:100 (embryos) and 1:500 (human cells); human
anti-K63 linked polyubiquitin (Apu3.A8; 30) at 1:500
(embryos) and 1:1000 (human cells); mouse anti-HP1g
(2 MOD-1G6, Euromedex) at 1:4000; rabbit anti
H3K9m3 (ab8898, Abcam) at 1:50; rabbit anti H3K4m3
(ab8580, Abcam) at 1:40; human serum against SmB/B0
(collected from Scleroderma patients at the Dermatology
Clinic of the Heinrich-Heine-University Duesseldorf,
Germany) at 1:100 (WB); mouse anti-tubulin (Tub 2.1,
Sigma) at 1:1000; mouse anti-20S (MCP231, Biomol) at
1:500 (WB); rabbit anti-20S (PW8155, Biomol) at
1:20–1:100; rabbit anti-26S (kindly provided by B.
Dahlmann, Berlin, Germany) at 1:50; mouse anti
RNAPII (H5; Covance) at 1:50; human serum against
RNAPII (kindly provided by R. Mierau, Aachen,
Germany) at 1:50; human serum against CenpC (#17,
were collected from Scleroderma patients at the
Dermatology Clinic at Heinrich-Heine-University
Duesseldorf, Germany) at 1:1000; rat anti-BrdU
(OBT0030, Oxford Biotechnology) at 1:50; mouse
anti-calnexin (H-70, Santa Cruz) at 1:1000; mouse
anti-SC35 (sc-35, Sigma) at 1:1000; mouse anti-ﬁbrillarin
(72B9, kindly provided by M. Pollard, Scripps Research
Institute, La Jolla; CA, USA) at 1:20.
Secondary antibodies (Jackson ImmunoResearch
Laboratories) conjugated to FITC, rhodamine, Cy2;
Cy3, or Cy5 were used at dilutions of 1:100 in IF.
Secondary antibodies were used at 1:10000 (anti-rabbit,
-human) and 1:5000 (anti-mouse IgG; IgM) in WBs.
Indirect IF and microscopy
Cells were seeded on coverslips, grown to subconﬂuence,
ﬁxed and permeabilized using procedures (i)–(iii):
(i) Rinsed in phosphate-buffered saline (PBS), ﬁxed in
methanol (5min,  20 C), permeabilized in acetone
(2min at  20 C).
(ii) Rinsed in PBS, ﬁxed in 4% formaldehyde (10% for-
maldehyde methanol free, Polysciences) in PBS
[10min, room temperature (RT)), permeabilized in
0.25% Triton X-100 (3min; RT).
(iii) Rinsed in PBS, ﬁxed in 4% formaldehyde in PBS
(20min, RT), washed three times with PBS,
permeabilized with 1% Triton X-100 (5min, RT).
Caenorhabditis elegans embryos were obtained by cutting
gravid hermaphrodites, preﬁxation of released embryos in
4% formaldehyde for 5–40min, freeze cracking between
slide and coverslip, direct ﬁxation in  20 C methanol for
5min and permeabilization in  20 C acetone for 2min.
After ﬁxation and permeabilization, cells or C. elegans
embryos were washed in PBS and subjected to IF as
described previously (31). Imaging was performed at RT
using (i) a 60x/1.25NA UPlanFl, a 60x/1.4NA planapo or
a 100x/1.4NA planapo objective on an inverted confocal
laser-scanning microscope (Fluoview IX70, Olympus) or
(ii) a 63x/1.4NA objective on a LSM 510Meta laser
scanning microscope (Zeiss). Figures were assembled in
Photoshop (Adobe).
Biochemical fractionation and chromatin isolation
Cells were grown in culture ﬂasks and left untreated or
exposed to chemicals as indicated. After the indicated
times, cells were detached by trypsination. Collected cells
were washed twice with PBS and then lysed in lysis buffer
consisting of 0.01M Tris–HCl pH 7.5; 0.01M NaCl,
0.015M MgCl2 and 0.5% Triton X-100 at 4 C. After cen-
trifugation at 2500g for 10min, the supernatant was col-
lected as cytoplasmic fraction while the pellet was further
resuspended and sonicated to obtain a complete nuclear
lysate. For chromatin-isolation collected cells were washed
twice in PBS and lysed in buffer A (0.01M HEPES pH
7.6; 0.01M KCl; 0.015M MgCl2; 0.34M Sucrose; 10%
Glycerol; 0.001M DTT, Pefablock) for 8min on ice.
After centrifugation at 1300g, the supernatant was col-
lected as cytoplasmic fraction while the pellet was
washed in buffer A, resuspended in buffer B (0.003M
EDTA; 0.0002M EGTA, 0.001M DTT; Pefablock) and
incubated for 45min on ice. After centrifugation at 1700g
for 5min, the supernatant was collected as soluble nuclear
fraction and the pellet was washed in buffer B and col-
lected as insoluble nuclear fraction/chromatin-enriched
fraction. The DNA in the insoluble nuclear fraction was
sheared.
Immunoblotting
Proteins from whole cell lysates or cell fractions separated
by sodium dodecyl sulphate–polyacrylamide gel electro-
phoresis (SDS–PAGE) were transferred to Hybond N
(Amersham) and incubated with indicated antibodies in
PBS containing 0.5% Tween-20 with 5% nonfat dried
milk. Bound antibodies were detected using horseradish
peroxidase-conjugated secondary antibodies and the
ECL system (Amersham), according to the manufacturer’s
instructions.
S5a-Pull down
Nuclear fractions were prepared as described above.
Pellets containing nuclear fractions were resuspended in
TBS containing 5% glycerol and 0.5% Triton X-100
followed by sonication. Binding was performed by incu-
bation of the nuclear fraction with GST-S5a agarose
(Biomol) overnight at 4 C. Bound proteins were washed
in TBS/5% glycerol/0.5% Triton X-100 and in one last
washing step without Triton X-100. Bound proteins were
boiled in loading buffer, separated in a 6% SDS–PAGE
and immunoblotted. 50mM glutathione was added to the
samples with GST-S5a agarose as a competitor to corrob-
orate speciﬁcity of RNAPII binding (Figure 6C, lane
GSH).
In vivo immunolabelling of nascent RNA transcripts
Fluorouridine (FU) incorporation assays were performed
to detect newly synthesized RNA as previously described
(32,33). Cells were grown on coverslips to subconﬂuence.
FU was added to the culture medium (0.02M working
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after 5–10min. Subsequently, cells were ﬁxed using 4%
formaldehyde/0.25% Triton X-100 and the halogenated
nucleotide was detected with a rat anti-BrdU antibody
(Sigma) at 1:50.
In situ localization of proteasomal proteolysis
Cells were seeded on coverslips and grown to
subconﬂuence. For in situ localization of proteasomal
protein degradation in subnuclear compartments
DQ-ovalbumin (DQ-Ova; 0.1–0.5mg/ml in PBS) or a
combination of DQ-Ova with DQ-BSA (0.1mg/ml in
PBS) was microinjected into the nucleus. DQ-Ova and
DQ-BSA are ﬂuorogenic substrates for proteases. A
strong ﬂuorescence quenching effect is observed when
proteins are heavily loaded with BODIPY dyes. Upon hy-
drolysis of DQ-Ova or DQ-BSA to single, dye-labelled
peptides by proteases, this quenching effect is relieved,
producing brightly ﬂuorescent products. Thus, ﬂuores-
cence intensity equals local proteolytic activity, and visu-
alizes an intracellular process that can be subjected to
kinetic imaging analyses. DQ-Ova and DQ-BSA ﬂuores-
cence either was imaged in living cells or by cell ﬁxation
10–60min post injection according to protocols
(i)–(iii)(see above).
Fluorescence in situ hybridization
Fluorescence in situ hybridization (FISH) was performed
as previously described (29,34). Brieﬂy, E3 cells were
grown on coverslips and induced with 6mg/ml doxycycline
overnight. Cells were rinsed in PBS, ﬁxed in 4% formal-
dehyde (20min, RT), washed twice with PBS and
incubated with 70% ethanol over night at 4 C. Cells
were rinsed twice in PBS and permeabilized with 0.5%
Triton X-100 (10min, RT). After washing with PBS,
cells were rinsed twice in 40% formamide/2  SSC
(5min each). They were hybridized overnight at 37 Ci n
30ml/coverslip of a solution containing 0.01 % RNase-free
BSA, 1.5mg single-stranded DNA (ssDNA)/tRNA, 2 
SSC, 40% formamide, and 10ng of probe. The cells
were washed twice with 40% formamide/2  SSC for
15min at 37 C and twice with PBS for 1h. Then the
cells were reﬁxed in 4% formaldehyde for 20min,
washed in PBS and immunolabelled. Cells were mounted
with Pro-Gold mounting medium. Imaging was per-
formed as described previously (29) with a 60 /1.4NA
planapo objective on an inverted microscope (1X81;
Olympus) connected to an air-cooled charge-coupled
device camera (Sensicam QE; Roper Scientiﬁc) run by
IPLab Spectrum software (Scanalytics).
Quantiﬁcation
Quantiﬁcation analysis of ﬂuorescence and WB was per-
formed with Metamorph image analysis software package
(MSD Analytical Technologies) or counted manually
using ﬂuoview (Olympus) or the Zeiss LSM image
browser (Zeiss). Linescans were taken from contrast-
enhanced blowups as indicated.
Fluorescence recovery after photobleaching and
ﬂuorescence recovery after photobleaching analysis
Fluorescence recovery after photobleaching (FRAP)
analysis was performed on a Zeiss LSM 510 Meta
confocal microscope, equipped with an argon laser
(488nm and 100mW power), and an incubation
chamber with temperature control and CO2 supply. Cell
measurements were performed at 37 C and 5% CO2
partial pressure. HEp-2 cells were grown in
Matek-Dishes to subconﬂuence and subjected to micro-
injection with 0.2mg/ml DQ-Ova at 37 C. Cells recovered
in 15min and were detected with a 63  oil / 1.4NA ob-
jective (Zeiss). For ATP depletion, cells were cultivated
post microinjection in medium with 0.01M sodium azide
and 0.05M 2-deoxyglucose at 37 C. Two to four proteo-
lytic foci per nucleus were selected for bleaching. Three
prebleach images were taken with 20mW/mm
2 (0.5%
AOTF transmission). Photobleaching was performed
with 2mW/mm
2 (100% AOTF transmission) for 31s.
Subsequent images were taken with 20mW/mm
2 (0.5%
AOTF transmission) to avoid bleaching during the acqui-
sition phase. Z-stacks were taken every 160s to account
for cell movement during the acquisition phase. Typically,
each z-stack contained around 10 images. In total, eight
z-stacks were taken per cell, corresponding to an observa-
tion time of  20min. Image analysis was performed with
ImageJ and Origin 8.0. First, unbleached foci inside the
prebleach image were used to ﬁnd the right image plane
containing the recovery information from the z-stack. The
new time stack was slightly smoothened. A region of
interest (ROI) was placed manually around each
bleached focus in each image. An additional ROI was
placed around the whole cell for correction of potential
photobleaching during the acquisition phase. To obtain
normalized and bleach corrected intensity versus time
plot, the data were normalized according to
IðtÞ¼
BðtÞ N0
NðtÞ B0
where B(t) is the intensity of the bleached spot ROI
changing with time, B0 is the intensity of the bleached
spot ROI in the prebleach image, N(t) is the intensity of
the whole cell ROI changing with time and N0 is the in-
tensity of the whole cell ROI in the prebleach image (35).
The normalized data of each focus were collected and a
mean normalized intensity versus time plot generated for
the different experimental conditions.
SMM
The mobility analysis of single proteolytic foci was per-
formed on a custom-built wide-ﬁeld epi-ﬂuorescence
microscope based on an Axiovert 200 microscope body
(Zeiss), equipped with a highly sensitive Andor iXon DV
860-BI EMCCD camera with 128 128 pixels and with a
Sapphire 100 DPSS-laser illumination with 488nm (36).
Single focus imaging was performed using a 63 oil/
1.4NA objective (Zeiss) and  2fps acquisition time at
RT. Single focus tracking was performed using
DiaTrack 3.03 (Semasopht). Calculation of the
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(37) with Origin 8.0 (Originlab). To obtain a diffusion
coefﬁcient the ﬁrst  10 linear points of each MSD plot
were ﬁtted with
r2 
¼ 4Dt
where <r
2> is the two-dimensional MSD, D is the diffu-
sion coefﬁcient and t the time lag.
RESULTS
Proteolytic microenvironments in the nucleus contain
ubiquitinated proteins, degrade different substrates
and are immobile
We have shown previously that proteasomal activity can
be visualized in nucleoplasmic foci by microinjection of
the ﬂuorogenic precursor substrate DQ-ovalbumin
(DQ-Ova) into the cell nucleus, and proteasome
inhibitor-sensitive detection of its ﬂuorescent cleavage
products by confocal laser-scanning microscopy (38). To
characterize such centres of proteolytic activity in more
detail, different cell types were analysed with respect to
nuclear localization and numbers of DQ-Ova foci. In
murine embryonic ﬁbroblasts (MEFs), human osteosar-
coma cells (E3) and human epithelial cells (HEp-2) ﬂuor-
escent DQ-Ova cleavage products are diffusely distributed
throughout the nucleoplasm, and concentrate in 7–90
bright foci per nucleus (Figure 1A, B and D). A HEp-2
nucleus contains an average of 29 proteolytic centres.
Confocal detection of simultaneously microinjected
DQ-Ova (green) and the likewise quenched DQ-BSA
(red) showed that both substrates are degraded in the
same proteolytic microenvironments (Figure 1C, micro-
graph, blowups, linescan). Similar results were obtained
by co-injection of DQ-Ova and the ﬂuorogenic precursor
substrate succinyl-LLVY-amino-methyl-coumarin (data
not shown).
Since it is not known if DQ-Ova or DQ-BSA is tagged
for proteasome-dependent degradation by poly-ubiquitin
chains, it was tested if proteolytic microenvironments
contain ubiquitinated substrates. To this end, micro-
injected DQ-Ova was double-labelled with antibodies
that speciﬁcally detect tetraubiquitin chains linked via
lysine (K) at position 48 or 63, respectively (30). Cleaved
DQ-Ova as well as K48-tetraubiquitin and K63-
tetraubiquitin are localized in a similar pattern of
multiple foci throughout the nucleoplasm (Figure 1D).
K63-linked tetraubiquitin additionally shows distinct
staining in the cytoplasm (Supplementary Figure S1).
Representative linescans and quantiﬁcation of ﬂuorescent
signals in 35 nuclei show that 57% of the proteolytic
centres colocalize with K48-tetraubiquitin and 60% pro-
teolytic centres colocalize with K63-tetraubiquitin
(Figure 1D, graph, right), suggesting degradation of en-
dogenous substrates in these domains.
Nuclear processes such as replication, DNA repair,
transcription and RNA maturation occur in highly
dynamic microenvironments (4). To determine the
mobility and dynamics of DQ-Ova degradation sites,
kinetic imaging techniques were applied. Single molecule
microscopy revealed that a proteolytic centre moves in an
area of 2 2 pixels within a time window of 150s. The
respective trajectory starts at pixel position 76/32 (y-axis/
x-axis), and moves to pixel position 78/34 over time
(Figure 1E, upper panel, right). The corresponding
graph of mean-square-displacement (MSD) values over
time shows a linear increase within the ﬁrst 75s, suggesting
free diffusion followed by a parabolic curve progression
that is probably due to a combination of free diffusion and
an additional directed movement (Figure 1E, lower panel).
It is important to note that the measurements were per-
formed in a conﬁned area of small scale, e.g. several pixels,
representing conditions where the intrinsic dynamics of
the cell system do matter. To account for intrinsic cell
movement linear MSD-values of 46 proteolytic foci from
13 cells were used for determination of a mean diffusion
coefﬁcient of 2 10
 5mm
2/s±0.3 10
 5mm
2/s, suggest-
ing that DQ-Ova degradation centres are nearly immobile.
Next, the dynamics of DQ-Ova proteolytic centres were
analysed by FRAP that enables observation of the
mobility of ﬂuorescently labelled molecule populations
due to their inherent photosensitivity (39). DQ-Ova was
microinjected into cells, selected proteolytic foci were
bleached and recovery of ﬂuorescent signals was
observed over time (Figure 1F, look up table depiction,
arrows). Accumulated data from FRAP analyses of 49
DQ-Ova microenvironments show that at 37 C proteolyt-
ic foci return in a biphasic manner that is characterized by
a fast increase of ﬂuorescence in the regime of three
minutes postbleach, followed by a slower recovery
(Figure 1G, black curve). Under physiological conditions
(37 C), ﬂuorescence recovery reaches 16% within 17.7mi.
In ATP-depleted cells, recovery is also biphasic, but
reduced, since it reaches a plateau of 11% recovery after
9min (Figure 1G, red curve). The FRAP experiments, as
presented here, suggest that recovery of ﬂuorescent
DQ-Ova cleavage products is mainly due to continuous
protein degradation within proteolytic sites. This assump-
tion is strengthened by the results of ATP depletion that,
among other things, inhibits ubiquitination and
proteasomal protein degradation. Consistent with an ex-
haustion of the protein degradation process, the
normalized ﬂuorescence intensity of proteolytic centres
immediately postbleach is signiﬁcantly reduced in
ATP-depleted versus control cells (Figure 1H).
Proteasomal activity locates to euchromatin
To characterize their association with chromatin, DQ-Ova
foci were double-labelled with DNA dyes,
heterochromatin-associated protein HP1g and histone
H3 that is trimethylated at lysine position 9 (H3K9m3).
The DNA dye topro3 stains euchromatic regions with a
homogeneous, transparent pattern throughout the nucleo-
plasm, and concentrates in bright heterochromatic areas,
especially in the periphery of nucleoli (Figure 2A; third
micrograph). The corresponding merged micrograph,
blowup and linescan show that DQ-Ova foci are
embedded in euchromatic regions, but excluded from
regions with high DNA concentration that indicate
4616 Nucleic Acids Research, 2011,Vol.39, No. 11Figure 1. Proteasomal proteolysis in the cell nucleus is spatially conﬁned. Proteasome-dependent protein degradation was monitored by microinjec-
tion of the ﬂuorogenic substrate DQ-Ova into nuclei. (A) Subnuclear localization of DQ-Ova degradation sites was analysed by confocal ﬂuorescence
microscopy in different mammalian cell types. Bar, 5mm. (B) Quantiﬁcation of proteolytic foci per nucleus in HEp-2 cells. The boxplot represents
data of 59 nuclei from eight independent experiments. (C) Comicroinjection of DQ-Ova and DQ-BSA into a HEp-2 cell nucleus shows that both
substrates are degraded in the same nuclear microenvironment (merge, blowup and linescan). Bar, 5mm. (D) Double labelling of DQ-Ova and
antibodies against K48- or K63-linked tetraubiquitin shows that polyubiquitinated proteins are components of proteolytic microenvironments
(merge, blowups and linescans). Quantiﬁcation of colocalization between green and red ﬂuorescence signals indicates that 57% of proteolytic foci
overlap with K48-linked and 60% with K63-linked polyubiquitinated proteins. Values represent means±SD from four independent experiments
each (n=35). Bar, 5mm. (E) Proteolytic foci are nearly immobile. DQ-Ova was microinjected into a HEp-2 cell nucleus (micrograph, dotted line)
and monitored with two frames/second over 200s. The trajectory shows the position of one proteolytic focus (micrograph, continuous circle) over
time. The graph (lower panel) depicts the mean square displacement (MSD) of this focus plotted against the time. The ﬁrst 10 linear points of the
curve were used to calculate a diffusion coefﬁcient (inset). (F) Fluorescence recovery after photobleaching (FRAP) experiments were performed on
HEp-2 cells that were microinjected with DQ-Ova into the nucleus. Micrographs show areas that contain proteolytic foci before the bleach pulse
(pre-bleach, left), immediately after the bleach pulse (post-bleach, middle), and after 17.7min of ﬂuorescence recovery (right). Images represent look
up tables from time-lapse FRAP data sets. Arrows label three bleach regions that contain one proteolytic focus each. (G) Quantiﬁcation of FRAP
experiments at 37 C without (37 C) or with treatment with 10mM sodium azide/50mM 2-deoxyglucose after microinjection (-ATP). The graph
shows mean values±SEM (bleached proteolytic foci=49 from eight independent experiments) as relative ﬂuorescence recovery after normalization
of the post-bleach levels to zero. (H) The graph shows post-bleach mean values±SEM as relative ﬂuorescence intensity after normalization to
pre-bleach levels.
Nucleic Acids Research, 2011,Vol.39, No. 11 4617Figure 2. Localization of proteasomal proteolysis in euchromatin. (A–C) Confocal ﬂuorescence micrographs of representative HEp-2 cells that were
microinjected with DQ-Ova (green) and double-labelled (red) with TO-PRO3 (A), HP1g (B) or H3K9m3 (C). Proteolytic foci are localized in
euchromatic regions (merges, blowups, linescans). Bar, 5mm. (D) HEp-2 cells were fractionated into a cytoplasmic (Cy), soluble nuclear (SN) or
chromatin-enriched nuclear fraction (Chr). Protein fractions were analysed by western blot to determine the levels of 20S proteasomes or signature
proteins of the fractions as control (nuclear, snRNP component SmB/B0; cytoplasm, tubulin). The enrichment of chromatin in respective fractions is
monitored by the concentration of histone proteins that occur as prominent bands between 14 and 20kDa (Ponceau). WCL, whole cell lysate.
(E) Micrographs of a representative HEp-2 cell microinjected with DQ-Ova into the nucleus and immunostained with antibodies against H3K4m3,
an epigenetic mark of transcriptionally active euchromatin. Thirty-one percent of the proteolytic foci are localized in transcriptionally active
euchromatin, whereas 69% are not locally associated (merge, blowups and linescan; six independent experiments, n=20). (F) Micrographs of a
representative HEp-2 cell that was microinjected with DQ-Ova into the nucleus and subjected to ﬂuorouridine incorporation to label sites of active
transcription. After ﬁxation, cells were immunostained with antibodies against BrdU to detect sites of FU incorporation. 51% of the proteolytic foci
are colocalized with sites of active transcription, whereas 49% are separated (merge, blowups and linescan; three independent experiments, n=17).
4618 Nucleic Acids Research, 2011,Vol.39, No. 11heterochromatin (Figure 2A). The exclusive localization
of proteolytic microenvironments in euchromatin was
corroborated by the absence of colocalization with hetero-
chromatin markers HP1g and H3K9m3 (Figure 2B and C;
micrographs, linescans).
Proteolytic activity in euchromatic regions consequently
raises the issue of association of proteasomes with chro-
matin. Immunoblots show that while proteasomes are pre-
dominately occurring in the cytoplasmic protein fraction,
they partially cofractionate with chromatin-free nuclear
fractions and, to a lesser extent, with chromatin-enriched
nuclear fractions that contain histone proteins (Figure 2D;
immunoblot and Ponceau stain). The colocalization and
cofractionation results suggest that proteasomal proteoly-
sis as well as proteasomes occur in nucleoplasmic micro-
environments that are characterized by a low
concentration of chromatin.
Proteasomal activity partially colocalizes with global
transcription
Since condensation of chromatin generally antagonizes
nuclear processes, active gene expression is mostly
located in euchromatin (14). Due to the localization of
proteasomal activity in euchromatic regions, we next
analysed the spatial relationship between sites of tran-
scriptional and proteolytic activity in the nucleoplasm.
Labelling of microinjected DQ-Ova and antibodies
against histone 3 that is epigenetically marked by
trimethylation at lysine position 4 (H3K4m3) during the
transcription process (40,41) shows a granular distribution
of H3K4m3 throughout the nucleoplasm (Figure 2E).
Quantiﬁcation of double-labelling experiments with
DQ-Ova indicates that 31% of proteolytic foci colocalize
with H3K4me3-marked chromatin, whereas the remaining
69% do not. Separation of proteolytic and transcriptional
sites can be described in more detail in respective linescans
that clearly show a central DQ-Ova focus (green) encased
by H3K4m3 signal (Figure 2E; linescan 1, red).
In addition to the antibody-based analysis, protein deg-
radation and transcriptional processes were observed sim-
ultaneously by DQ-Ova proteolysis and in situ run on
assays that monitor incorporation of the nucleotide
analogue ﬂuorouridine (FU) during transcript elongation.
While ﬂuorescent degradation products of DQ-Ova con-
centrate in an average of 29 distinct foci, nascent RNAs
are distributed in a granular nucleoplasmic pattern that is
composed of hundreds of transcriptionally active micro-
environments (Figure 2F, red). The Cook and Hager labs
determined 1900–8000 transcription sites per human
nucleus (10,42,43). Notwithstanding the abundance of
transcriptionally active microenvironments, quantiﬁcation
showed that only 51% of proteolytic centres colocalize
with nascent RNAs (Figure 2F), and only 17%
colocalization was observed between proteasomes and
nascent RNAs (data not shown). In line with the
H3K4m3 signal-based results, simultaneous visualization
of proteolysis and global transcription identiﬁes a limited
local association of these two nuclear processes that is
precluded from in-depth analyses by the heterogeneity of
ongoing gene programmes due to concurrent detection of
various cell cycle and transcriptional phases.
Proteasomal activity and proteasomes are not colocalized
with every induced transcription site
To examine positioning between proteasomal proteolysis
and transcription in a deﬁned gene programme, a cell
system was used that exclusively visualizes single tran-
scription sites. It is based on previously established
methods that allow for observation of gene expression
from the time a deﬁned gene is induced via the levels of
DNA, RNA and respective protein product in living cells
(29,44). The system consists of a stable cell line with a
tandem transgene array ( 50 copies) inserted into a
single site. Nascent RNA is detected by FISH against a
speciﬁc intron of the b-globin gene (intron 1) or by ex-
pressed MS2 bacteriophage coat protein fused to green
ﬂuorescent protein (GFP) and bound to MS2 stem–
loops placed in the 30-untranslated region (UTR) of the
transcript. Additionally, the transcript encodes a cyan
ﬂuorescent protein (CFP) fusion protein that is targeted
to peroxisomes when RNA processing, mRNA transport
and translation are completed.
Intron 1 of b-globin RNA concentrates at the site of the
gene array in a single bright spot (Figure 3B-2, -4, -6 and -
8). Proteolytic products of DQ-Ova localize in a homoge-
neous pattern throughout the nucleoplasm, and concen-
trate in brighter foci. Despite the analogous distribution,
proteolytic activity is excluded from the induced transcrip-
tion site (Figure 3B-8). The presence of the CFP fusion
protein in peroxisomal spots indicates that the entire
process of gene expression has gone to completion
(Figure 3B-5), and suggests that local association of
proteasomal activity with the promoter/gene array is not
required for transcription of the b-globin transgene.
In order to rule out the possibility that local association
of proteasomal protein degradation is required at the gene
array that cannot be visualized by DQ-Ova proteolysis, we
next analysed the distribution of 20S proteasome core par-
ticles in correlation with transcription of fusion protein
MS2-GFP (Figure 3C). MS2-GFP distributes in a
smooth homogeneous pattern throughout the nucleo-
plasm and concentrates in a bright spot that indicates
nascent MS2 transcripts, containing MS2 stem–loop
RNA, at the site of the gene array (Figure 3C-2, -4, -6
and -8). 20S proteasomes locate to the cytoplasm and nu-
cleoplasm, excluding nucleoli (Figure 3C-3). Despite their
ubiquitous distribution in the nucleoplasm, 20S prote-
asomes do not colocalize with MS2-GFP at the induced
transcription site (Figure 3C-8), indicating that recruit-
ment of proteasomes to the respective promoter is not
required for transcription of MS2 RNA. The presence of
the CFP fusion protein in bright peroxisomal spots
(Figure 3C-5) demonstrates that the entire process of
gene expression has gone to completion without local
presence of proteasomes at the gene array.
We next examined the local organization of
proteasomal proteolysis and an endogenous gene array
that represents a natural platform for gene expression.
Ribosomal DNA (rDNA) genes are organized as
Nucleic Acids Research, 2011,Vol.39, No. 11 4619tandem repeats in nucleolar organizer regions (NORs)
that enable transcription of the huge amounts of riboso-
mal RNA needed for the assembly of ribosomes (45).
NORs imaged in HEp-2 cells by a speciﬁc autoimmune
serum (Figure 4A and D, red) or concentration of silver
ions (AgNOR, Figure 4B and E, dark grey) are located
predominately in nucleoli (right column, blowups, white
circles) and to a lesser extent throughout the nucleoplasm.
Colocalization analysis with either 20S proteasomes
(Figure 4A and B, 20S, green) or DQ-Ova (Figure 4D
and E, green) by confocal microscopy shows (i) no prote-
asome signal in 88% of the NORs and 82% of the
AgNORs (Figure 4C), and (ii) that 90% proteolytic foci
occur without NOR association and 91% without
AgNOR association (Figure 4F). These results suggest
that neither the presence of proteasomes nor their
Figure 3. Proteasomes and proteasomal activity are not localized at induced genes/sites of transcription initiation. (A–C) Stable human U2OS cell
line expressing a transgene from an inducible promoter. (A) Schematic of the construct that was stably integrated into the genome of the cell line E3.
It consists of the human b-globin gene with three exons, two introns, and a short 50 untranslated region (UTR). Exon 3 was truncated and fused
in-frame to CFP containing the peroxisomal targeting tripeptide SKL at its COOH terminus; thus, functional transcription and translation induces
ﬂuorescent peroxisomes. The 30UTR encompasses 18 MS2 stem–loop repeats, which provide tight binding sites for the MS2 coat protein when
transcribed. Expression is driven by a minimal CMV promoter (Pmin) under the control of the tetracycline response element (TRE) and inducible by
the presence of doxycycline (dox) by the transactivator (rtTA) (29). (B) Induced E3 cells were microinjected with DQ-Ova into the nuclei, ﬁxed,
permeabilized and assayed by FISH with Cy3-labeled probes to intron 1. The induced transcription site appeared as a bright focal signal of intron 1
(B2, blowup B6, arrow). The panels B4 and B8 depict the merge of the intron 1 signal with proteolytic microenvironments (B3, blowup B7) showing
that there is no proteolytic activity at the induced transcription site. Note that (i) the intron 1 signal and DQ-Ova are pseudo-coloured, and (ii) the
direct ﬂuorescence of the b-globin-CFP in peroxisomes is weaker than in (C) due to the FISH procedure, but, nevertheless, indicates successful
induction of transgene expression. (C) Fluorescent micrographs of an E3 cell that was transfected with MS2-GFP, induced for transgene expression,
ﬁxed, permeabilized and immunostained with antibodies against 20S proteasomes (C3, C7 blowup). The direct ﬂuorescence of b-globin-CFP in
peroxisomes indicates completed expression of the gene (C5), whereas the induced transcription site can be visualized by direct ﬂuorescence via
MS2-GFP (C2, blowup C6, arrow). The panels C4 and C8 depict the merge of the MS2-GFP and the 20S proteasome staining in pseudo-colour
showing that proteasomes are absent from the induced transcription site.
4620 Nucleic Acids Research, 2011,Vol.39, No. 11activity at NORs is required for transcription and expres-
sion of rDNA. The completeness of rDNA gene expres-
sion, e.g. rRNA biogenesis, was monitored by ribosome
proﬁling (data not shown).
Transcription of early genes in C. elegans embryos occurs
without local association of proteasomes or their
substrates
We have shown that proteolytic activity is localized
neither at the inducible transcription site of the human
b-globin transgene array nor at endogenous rRNA gene
arrays. To validate the relevance of these results in vivo,
we analysed embryos of the nematode C. elegans.
Caenorhabditis elegans embryos are primarily controlled
by maternal factors; thus, the expression of the early
genes during the ﬁrst cell divisions represents a deﬁned
gene programme (46–48). Gravid hermaphrodites were
cut and released embryos freeze-cracked, ﬁxed and
labelled with antibodies against hyperphosphorylated
RNAPIIo that indicate transcriptional elongation (49).
The elongating RNAPIIo-molecules are localized
throughout the nucleoplasm of worm embryos in a
punctuated pattern (Figure 5B–G, red). It should be
noted that not all nuclei show RNAPIIo staining,
because in C. elegans mRNA synthesis is inhibited in the
early embryonic germ lineage (49). Labelling of the ubi-
quitin–proteasome system in C. elegans embryos reveals
that proteasomes are distributed in the cytoplasm and
throughout the nucleoplasm in distinct foci and a diffuse
localization pattern (Figure 5B, green). Proteins marked
for degradation via K48-linked tetraubiquitin occur in the
cytoplasm and nucleoplasm. In the nucleus, they localize
within larger foci that develop to distinct microdomains in
late embryonal stages (Figure 5C–G, green). Independent
of the developmental stage of the embryo proteasomes
and tetraubiquitinated proteins are generally not
colocalized with RNAPIIo foci. Local overlap between
proteasomes or K48-linked nuclear proteins with
RNAPIIo-signals could only be observed in scattered
nuclei (Figure 5B, F and G; blowups, arrows, yellow).
Consistent with the results of the gene arrays, proteasomes
and their substrates, e.g. K48-linked tetraubiquitinated
proteins, are localized separately from early transcribed
genes in C. elegans.
Inhibition of transcription induces nuclear protein
degradation centres
The spatiotemporal analysis of proteolytic and transcrip-
tional processes has revealed that neither proteasomes nor
proteasomal degradation have to be locally associated
Figure 4. Proteasomes and proteasomal activity are not localized at sites of ribosomal RNA transcription. Endogenous gene array: ribosomal genes
are labelled by a human patient serum against nucleolar organizer regions (NORs, A,D) or silverstaining (B and E). (A, B, D and E) Confocal
ﬂuorescence micrographs of NORs in representative HEp-2 cells double-labelled with antibodies against proteasomes (green; A and B) or micro-
injected with DQ-Ova (green; D, E). Bar, 5mm. Quantiﬁcation of (C) NORs in relation to proteasomes from three independent experiments (n=300)
and (F) the positioning of proteolytic foci in relation to NORs from three independent experiments (NORs: n=19; AgNORs: n=22).
Nucleic Acids Research, 2011,Vol.39, No. 11 4621Figure 5. Proteasomes and tetraubiquitinated nuclear proteins are not localized at early transcribed genes in C. elegans embryos. (A) Schematic of
the anatomy of a gravid C. elegans hermaphrodite with fertilized eggs/embryos in the uterus. (B–G) Confocal ﬂuorescence micrographs of repre-
sentative C. elegans embryos in different developmental stages double-labelled with antibodies against hyperphosphorylated RNAPIIo (red) and (B)
proteasomes (green) or (C–G) K48-linked polyubiquitin (green). Neither proteasomes nor proteins, which are tagged for proteasomal degradation,
are spatially associated with elongating RNAPIIo. Scattered nuclei show colocalization (right column, insets, arrows, yellow). nu, nucleus. Bar,
20mm.
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pression. However, previous results in yeast indicate a
physical interaction of RNAPII/template DNA and
proteasome-dependent degradation of RNAPII under
conditions of stalled transcription or transcriptional ter-
mination (27). In order to explore the distribution of
proteasomal activity when transcription is inhibited,
DQ-Ova foci were localized in nuclei of actinomycin D
(AMD)-treated cells. While the number of proteolytic
microenvironments per nucleus does not change after in-
hibition of transcription, a subpopulation of DQ-Ova foci
redistributes to enlarged rounded speckles that contain the
non-snRNP splicing factor SC35 (Figure 6A, lower panel,
linescan). A detailed list of rounded speckle components
and confocal micrographs that show recruitment of
RNAPII to these subnuclear microenvironments are avail-
able in Supplementary Data (Supplementary Table 1;
Supplementary Figure S2). Inhibition of proteasomal
activity by MG132 corroborates that especially the differ-
entially phosphorylated forms of RNAPII represent sub-
strates of proteasome-dependent protein degradation as
shown by increased signal intensity between the prevalent
bands representing RNAPIIo (240kDa) and RNAPIIa
(220kDa), respectively (Figure 6B and D, third lane).
Consistent with this, pull-down experiments show that
hyperphosphorylated RNAPII (RNAPIIo) as well as
hypophosphorylated RNAPII (RNAPIIa) interact with
subunit S5a of the 19S regulator which recognizes
ubiquitinated substrates (Figure 6C). The inhibition of
transcription by AMD induces a destabilization of
RNAPIIa that can be partially rescued by MG132
(Figure 6D). These results suggest that inhibition of tran-
scription by the DNA intercalator AMD induces a local
association of proteolytic microenvironments with
rounded speckles that correlates with degradation of
their protein components, e.g. RNAPII.
To strengthen the idea that transcription-off situations
induce local association of proteolytic centres with nuclear
proteins that are involved in gene expression, RNA poly-
merase I (RNAPI) was speciﬁcally inhibited with subtoxic
concentrations of mercuric chloride (HgCl2) as described
previously (31). Incubation of HEp-2 cells with HgCl2 for
4h induces nucleoplasmic clusters containing RNAPII,
20S proteasomes and ﬁbrillarin (Figure 6E). Fibrillarin
is normally located in the nucleolus and has a role in
early processing and modiﬁcation of ribosomal RNA,
and ribosome assembly (50). HgCl2 induces the redistribu-
tion of ﬁbrillarin into nucleoplasmic clusters and its
proteasomal degradation (31). Co-microinjection of
DQ-Ova and HgCl2 results in increased nucleoplasmic
colocalization of ﬁbrillarin with proteolytic microenviron-
ments/centres (Figure 6F) corroborating the idea that in-
hibition of RNAPI-dependent transcription induces the
redistribution of ﬁbrillarin and its degradation in the nu-
cleoplasm (31).
DISCUSSION
Nuclear processes such as DNA replication, DNA repair,
transcription of RNAs and their processing are organized
in dynamic microenvironments that are functionally con-
nected to the ubiquitin–proteasome system via proteolytic
and non-proteolytic pathways (51,52). While the import-
ance of proteasome-dependent protein degradation for
nuclear function is generally acknowledged, the investiga-
tion of local proteasomal activity in the nucleus is still in
its infancy. Yet, a crucial determinant for the lifetime of a
protein or protein complex is if the proteolytic machinery
is within reach or positioned at a distance. Consistent with
this idea, it was shown that degradation of several nuclear
proteins is correlated with their subnuclear localization
(31,53–56).
We recently developed an application that enables lo-
calization of proteasome-dependent proteolysis in the nu-
cleoplasm (38,57), and show here that proteolytic
microenvironments follow the paradigm of nuclear organ-
ization (1–4) since they occur as focal domains in euchro-
matic regions. The analysis of spatial interactions between
proteolytic and transcriptional sites reveals that (i) local
positioning of these two nuclear processes is variable and
(ii) at least some genes do not require local proteolytic
activity and the presence of proteasomes at the promoter
for execution of gene expression. The absence of cleaved
DQ-Ova as well as proteasomes at an induced b-globin
gene array, and detection of respective gene products in
the cytoplasm, indicates that all stages of gene expression
such as transcriptional initiation, elongation, RNA pro-
cessing, RNA transport and translation have been
completed without proteasomal activity at the corres-
ponding transcription site. These results ﬁnd conﬁrmation
in observations that endogenous rDNA gene arrays are
likewise not locally associated with proteasomes and
proteasomal activity. Most importantly, it is shown here
that embryonic transcripts in C. elegans are synthesized
under conditions of distantly positioned proteasomes in
relation to transcriptional elongation. Taken together,
the results somewhat conﬁne the model that suggests re-
cruitment of 26S proteasomes to initiated transcription
sites, and promotion of transcriptional elongation by in
situ degradation of components of the initiation machin-
ery (58).
Investigation of the spatial and temporal organization
of proteasomal proteolysis and transcription on a global
level, as we also performed, conﬁrms that expression of
genes does not always require local association of the ubi-
quitin–proteasome system. The idea of association
patterns that depend on the different phases of the tran-
scription cycle could integrate conﬂicting literature con-
cerning the demonstration of proteasomes and
proteasomal subunits at promoters (20,26,59,60). It
should also be noted that all these studies were antibody
based and, thus, did not particularly include analysis of
proteolytic activity, as presented here. As a result, a local
involvement of proteasomal protein degradation in tran-
scriptional initiation and elongation should not generally
be anticipated.
A different paradigm emerges under transcription-off
conditions. Inhibition of transcription invariably induces
formation of proteolytically active microenvironments in
the nucleoplasm that contain components of the ubiqui-
tin–proteasome system and the transcription machinery.
Nucleic Acids Research, 2011,Vol.39, No. 11 4623The induction of these proteolytic microenvironments is
correlated with proteasome-dependent degradation of
transcriptionally relevant proteins such as RNAPII.
Thus, it is suggested that local concentration of
proteasomal activity occurs at sites of interrupted
transcription and might aid to clear the respective chro-
matin from the transcription complex. This idea has been
put forward previously when it was shown that prote-
asomes physically and functionally interact with chroma-
tin at sites of stalled transcription (27). It was
Figure 6. Upon transcriptional inhibition, components of the gene expression machinery cluster in proteolytic microenvironments and are degraded
by proteasomes. (A) Double-labelling of DQ-Ova and antibodies against non-snRNP splicing factor SC35 in untreated (upper panel) or
AMD-treated (4h, lower panel). AMD-treatment induces bright rounded speckles that partially contain proteolytic activity (bottom, merge,
blowup and linescan). (B) Whole cell lysates of HEp-2 cells treated with increasing concentrations of proteasome inhibitor MG132 for 16h were
subjected to WB to determine the levels of RNAPII, and centromere protein CENP-C (loading control). (C) A pull-down assay with the 19S
regulator subunit S5a, followed by a WB with antibodies against RNAPII, shows physical association between S5a and RNAPII. IN, input; GSH,
speciﬁcity control. (D) Whole cell lysates of HEp-2 cells that were left untreated or treated with 2.5mM MG132 for 16h or with 1mg/ml AMD for 4h
or a combination thereof, were subjected to western blot analysis to determine the concentration of RNAPII and centromere protein CENP-C as
loading control. (E) Confocal immunoﬂuorescence indicates partial colocalization of ﬁbrillarin, 20S proteasomes and RNAPII in nucleoplasmic
clusters after 4h of HgCl2 treatment (+HgCl2, merge, blowup, linescan). Respective quantiﬁcation shows a 10-fold increase of colocalization in
HgCl2-treated cells. Values represent means from two independent experiments (n=127). (F) Microinjection of DQ-Ova (upper panel) or a com-
bination of DQ-Ova with HgCl2 (lower panel) shows that a subpopulation of HgCl2-induced nucleoplasmic ﬁbrillarin clusters contain proteolytic
activity (merge, blowups, linescans).
4624 Nucleic Acids Research, 2011,Vol.39, No. 11demonstrated that transcriptional arrest at DNA lesions
recruits the ubiquitin ligase Nedd4 and induces
ubiquitination of RNAPII (61,62). Thus, nucleoplasmic
structures such as enlarged, rounded speckles (63–65)
might represent junkyards that function as active protein
degradation centres when nuclear processes are inhibited,
and respective (ribo-) nucleoprotein complexes rendered
redundant. Consistent with this, we show here for the
ﬁrst time that rounded speckle domains are proteolytically
active.
Taken together, local concentration of proteolytic
activity represents a versatile tool for regulation of gene
expression. The formation of protein degradation centres
seems to be co-ordinately organized with nuclear
processes such as transcription that likewise occur in
conﬁned microenvironments in response to respective
cellular stimuli and requirements. In line with this idea,
recruitment of 20S proteasome core particles to the
promoter under transcription-off conditions was
demonstrated previously by shutting down the vascular
endothelial growth factor (VEGF) promoter, and
time-resolved chromatin immunoprecipitation (ChIP)
analysis (66). An attractive hypothesis is that recruited
proteasomes form a proteolytic microenvironment and
degrade HIF-1 or other transcription factors at the
promoter. Notably, association of the 19S regulator with
the VEGF promoter remained constant underlining a 20S
core particle-independent and non-proteolytic role of 19S
regulatory caps in transcriptional processes (20,21,66).
Since the functional architecture of the nucleus is
characterized by considerable dynamics of its structures,
it will be important to advance techniques that likewise
enable characterization of the dynamics of
proteasome-dependent proteolysis and its nuclear sub-
strates. Kinetic imaging of proteolytic foci by single
molecule microscopy and FRAP as performed in this
study deﬁnes nuclear microenvironments of DQ-Ova deg-
radation as immobile. This immobility argues against a
model that proteolytic centres roam the nuclear space
and scan it for potential substrates. Thus, a major topic
of future investigations concerns the identiﬁcation of mo-
lecular triggers that initiate and regulate local proteolytic
activity. Given the distinct positioning of proteasomal
proteolysis with respect to transcription sites, it will be
important to elucidate if nuclear distribution patterns of
protein degradation contribute to selective tuning of dif-
ferent gene programmes.
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